Forma Therapeutics (Cambridge, MA) a development-stage screening and discovery company focused on cancer therapies, closed a $25.5M Series B financing. Participants include Lilly Ventures, Novartis Option Fund and Bio*One Capital.

Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb